These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23037729)

  • 1. [Standard therapy for chronic myelogenous leukemia].
    Kimura S
    Rinsho Ketsueki; 2012 Oct; 53(10):1571-80. PubMed ID: 23037729
    [No Abstract]   [Full Text] [Related]  

  • 2. The future is now for the treatment of chronic myelogenous leukemia.
    Becze E
    ONS Connect; 2007; 22(8 Suppl):69-70. PubMed ID: 17824573
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chronic myelogenous leukemia: management of treatment-related adverse events].
    Takahashi N
    Rinsho Ketsueki; 2012 Oct; 53(10):1581-8. PubMed ID: 23037730
    [No Abstract]   [Full Text] [Related]  

  • 4. Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.
    Dika E; Barisani A; Vaccari S; Fanti PA; Ismaili A; Patrizi A
    J Drugs Dermatol; 2013 May; 12(5):512-3. PubMed ID: 23652942
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic myeloid Leukemia - clinical practice according to the JSH guideline for hematological malignancies].
    Yahagi Y
    Gan To Kagaku Ryoho; 2014 May; 41(5):567-71. PubMed ID: 24956628
    [No Abstract]   [Full Text] [Related]  

  • 6. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P; Das NK; Sil A; Chakrabarti P
    J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
    [No Abstract]   [Full Text] [Related]  

  • 7. Vocal fold hemorrhage in a CML patient after Glivec treatment.
    Shim HS; Woo SH
    Acta Oncol; 2013 May; 52(4):866-8. PubMed ID: 23153030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of chronic myeloid leukemia by imatinib].
    Kizaki M
    Rinsho Ketsueki; 2010 Oct; 51(10):1377-85. PubMed ID: 20962470
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple eruptive dermatofibromas related to imatinib treatment.
    Llamas-Velasco M; Fraga J; Solano-López GE; Steegmann JL; García Diez A; Requena L
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):979-81. PubMed ID: 24321053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chronic myeloid leukemia treatment and human immunodeficiency virus infection].
    Campillo-Recio D; Perez-Rodriguez L; Yebra E; Cervero-Jimenez M
    Rev Clin Esp (Barc); 2014 May; 214(4):231-2. PubMed ID: 24564991
    [No Abstract]   [Full Text] [Related]  

  • 11. Trends in the management of chronic myelogenous leukemia.
    Kantarjian H
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S41-5. PubMed ID: 16280112
    [No Abstract]   [Full Text] [Related]  

  • 12. New generation leukaemia drugs are on their way.
    Nelson L
    Drug Discov Today; 2004 Sep; 9(17):732-3. PubMed ID: 15450235
    [No Abstract]   [Full Text] [Related]  

  • 13. Good clinical practice in chronic myeloid leukemia: advances and prospects at the Institute of Oncology of Moldova.
    Musteata V
    J BUON; 2010; 15(1):188-9. PubMed ID: 20414949
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocytosis: the mysteries within.
    Munoz J; Guo Y
    Am J Hematol; 2012 Feb; 87(2):197. PubMed ID: 21815181
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA approves Gleevec for pediatric leukemia.
    FDA Consum; 2003; 37(4):6. PubMed ID: 12971334
    [No Abstract]   [Full Text] [Related]  

  • 16. Revised advice on use of imatinib for chronic myeloid leukaemia.
    Campbell K
    Nurs Times; 2003 Oct 14-20; 99(41):20-1. PubMed ID: 14603651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib for chronic myeloid leukemia: the impact of its effectiveness and long-term side effects.
    Smith BD
    J Natl Cancer Inst; 2011 Apr; 103(7):527-9. PubMed ID: 21422404
    [No Abstract]   [Full Text] [Related]  

  • 18. Current status of imatinib as frontline therapy for chronic myeloid leukemia.
    Marin D
    Semin Hematol; 2010 Oct; 47(4):312-8. PubMed ID: 20875547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cancer 'smart bomb'. A new drug shows hope of conquering a form of leukemia by targeting the misbehaving cells.
    Kalb C
    Newsweek; 2000 Dec; 136(25):68. PubMed ID: 11126146
    [No Abstract]   [Full Text] [Related]  

  • 20. Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST).
    Hochhaus A
    Ann Hematol; 2004; 83 Suppl 1():S65-6. PubMed ID: 15124676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.